Multiple Myeloma News
JAK1 Inhibitor NS-229 Granted FDA Orphan Drug Designation to Treat Allergic Autoimmune Condition
Source: Pharmacy Times articles NS-229 is a Janus kinase 1 (JAK1) inhibitor being investigated in eosinophilic granulomatosis with polyangiitis, a rare autoimmune condition that can cause severe allergic and asthmatic symptoms through inflammation of nerve cells. Read...
Recent Clinical Trial Highlights for NSCLC Treatment
Source: Pharmacy Times articles A panelist discusses how recent clinical trials for EGFR-positive non–small cell lung cancer (NSCLC) have expanded treatment options beyond single oral agents, with studies like FLAURA2, MARIPOSA, and PAPILLON demonstrating significant...
Integrating Clinical Trial Findings Into Everyday Pharmacy Practice
Source: Pharmacy Times articles A panelist discusses how combining therapies for EGFR-positive non–small cell lung cancer (NSCLC) increases both benefits (improved progression-free survival, response rates, and duration of response) and adverse effects, emphasizing...
RSV and Aging: Understanding Increased Vulnerability
Source: Pharmacy Times articles New research reveals how aging weakens immune responses to RSV in older adults, increasing severity and hospitalization risks. Read More
FDA Approves Penpulimab-Kcqz for Indications in Nonkeratinizing Nasopharyngeal Carcinoma
Source: Pharmacy Times articles The treatment received indications as a monotherapy and in combination regimen with carboplatin or cisplatin and gemcitabine. Read More
For Colon Cancer That No Longer Responds to Treatment, A New Drug Combination Offers Hope
Source: Pharmacy Times articles Patients in a Phase 3 clinical trial who received sotorasib and panitumumab lived longer, suggesting the combination therapy could become the new standard of care. Read More
Sacituzumab Govitecan-hziy Plus Pembrolizumab Improves PFS in Patients With Metastatic Triple-Negative Breast Cancer
Source: Pharmacy Times articles The combination yielded superior progression-free (PFS) survival compared with standard of care. Read More
From Workflow Integration to Patient Outcomes: The Expanding Role of PQIs
Source: Pharmacy Times articles Ginger Blackmon, PharmD, explains how NCODA’s Positive Quality Interventions (PQIs) help improve oncology care by guiding best practices, supporting teamwork, and streamlining workflows. Read More
Hormonal Contraceptive Initiation Associated With Increased Risk of Depression Postpartum in First-Time Mothers
Source: Pharmacy Times articles Because mothers are already at risk of depression postpartum, health care professionals must properly counsel mothers on hormonal contraceptives. Read More
Intravenous Immunoglobulin Does Not Improve Clinical Outcomes Compared With Tocilizumab in Severe COVID-19
Source: Pharmacy Times articles A study reveals IVIG treatment shows no significant benefits over tocilizumab for severe COVID-19, highlighting higher adverse events and costs. Read More